OakChart

Globus Medical Inc

GMEDHealthcare·Medical Devices·USA·Mid·NYSE·Nov 11 • 3:59 PM ET

75.39+0.16 (0.21%)
2026-11-12 05:10 CET
Market cap
10,122.01 USD m
Revenue, TTM
3,139.61 USD m
Net income, TTM
557.64 USD m
Free cash flow, TTM
766.55 USD m
EPS diluted, TTM
4.07
P/E
18.52
Compare

Price

GMED against its 20, 50 and 200-day averages
2050200beat
70.0075.0080.0085.0090.004.6M9.3MVolumeMay 26Jun 26Jul 26Aug 26Sep 26Oct 26Nov 26GMEDclose 75.3920-day 79.1250-day 76.84200-day 82.8975.3952w low

25.6% under the 52-week high of 101.40 on 8 Jan 2026. 52-week low 70.40 on 6 Nov 2026. Last 15 sessions, 25.2% high to low

Volume 1.20× normal · the line is the 50-bar volume average

Profile

GMED
52-week range, 16% of the way up
70.39101.4

Globus Medical, Inc. operates as a medical device company that develops and commercializes healthcare solutions. It engages in developing products that promote healing in patients with musculoskeletal disorders. The firm classifies products into Innovative Fusion and Disruptive Technology. It operates through the United States and International geographical segments. The company was founded by David C. Paul, David D. Davidar and Andrew Iott in 2003 and is headquartered in Audubon, PA.

IndexRUI
Employees6000
IPOAug 03, 2012
Beta0.96
ATR, 14d3.52
Rel volume1.20
Short float8.66%
Insider own17.32%
Inst own93.99%

Snapshot

6 groups

Valuation

IndexRUI
Market Cap9.99B
Enterprise Value9.58B
Income557.64M
Sales3.14B
Book/sh36.15
Cash/sh3.91
Dividend Est.-
Dividend TTM-
Dividend Ex-Date-
Dividend Gr. 3/5Y- -
Payout0.00%
Employees6000
IPOAug 03, 2012

Ratios

P/E18.52
Forward P/E14.10
PEG1.02
P/S3.18
P/B2.09
P/C19.30
P/FCF13.03
EV/EBITDA9.57
EV/Sales3.05
Quick Ratio2.67
Current Ratio4.30
Debt/Eq0.02
LT Debt/Eq0.02
Option/ShortYes / Yes

Earnings

EPS (ttm)4.07
EPS next Y5.35
EPS next Q1.29
EPS this Y25.11%
EPS next Y7.35%
EPS next 5Y13.76%
EPS past 3/5Y28.43% 31.11%
Sales past 3/5Y42.17% 30.08%
EPS Y/Y TTM32.22%
Sales Y/Y TTM13.35%
EPS Q/Q18.12%
Sales Q/Q-0.69%
EarningsNov 05 AMC
EPS/Sales Surpr.2.77% -3.62%

Ownership

Insider Own17.32%
Insider Trans-0.36%
Inst Own93.99%
Inst Trans4.78%
ROA10.50%
ROE12.13%
ROIC11.40%
Gross Margin65.47%
Oper. Margin22.96%
Profit Margin17.76%
SMA20-4.72%
SMA50-1.89%
SMA200-9.05%
Trades-

Technical

Shs Outstand110.24M
Shs Float109.23M
Short Float8.66%
Short Ratio6.00
Short Interest9.46M
52W High101.40 -25.65%
52W Low70.39 7.10%
Volatility5.87% 3.76%
ATR (14)3.52
RSI (14)45.83
Beta0.96
Rel Volume1.20
Avg Volume1.58M
Volume1,899,797

Performance

Perf Week-13.44%
Perf Month-1.22%
Perf Quarter-12.28%
Perf Half Y-0.24%
Perf YTD-13.65%
Perf Year-11.24%
Perf 3Y70.72%
Perf 5Y2.40%
Perf 10Y251.47%
Recom1.82
Target Price93.77
Prev Close75.23
Price75.39
Change %0.21%

Analyst ratings

latest 10 of 20
DateActionAnalystRating changeTargetImplied
Nov 06, 2026DowngradeBBMO Capital MarketsOutperform → Market Perform$78+3.5%
Jul 28, 2026InitiatedUUBSNeutral$82+8.8%
Jul 09, 2026InitiatedBBMO Capital MarketsOutperform$94+24.7%
Jan 30, 2026UpgradeNNeedhamHold → Buy$112+48.6%
Jan 27, 2026InitiatedTTD CowenBuy$110+45.9%
Nov 07, 2025UpgradeTTruistHold → Buy$93+23.4%
Nov 07, 2025UpgradeBBofA SecuritiesNeutral → Buy$91+20.7%
Oct 28, 2025ResumedSStifelHold$64-15.1%
May 27, 2025DowngradeBBTIG ResearchBuy → Neutral
Jan 10, 2025UpgradeBBofA SecuritiesUnderperform → Neutral$97+28.7%

Peers

Mkt cap
TickerCompanyMkt cap
ATECAlphatec Holdings Inc1.14B
ZBHZimmer Biomet Holdings Inc20.34B
OFIXOrthofix Medical Inc292.66M
SNNSmith & Nephew plc ADR12.99B
SYKStryker Corp121.36B
MDTMedtronic Plc129.98B
SIBNSI-BONE Inc1.13B
ENOVEnovis Corp1.65B
JNJJohnson & Johnson675.03B
ISRGIntuitive Surgical Inc155.83B

Insider trading

latest 14 of 37
InsiderRelationshipDateTransactionCostSharesValueTotal heldForm
TOBIN JAMES RDirectorNov 10 '26Proposed Sale75.1141,6663,129,392Nov 10 03:11 PM
RHOADS ANN DDirectorNov 04 '26Sale85.005,000425,00035,384Nov 05 05:33 PM
RHOADS ANN DDirectorNov 04 '26Proposed Sale85.005,000425,000Nov 04 02:57 PM
TOBIN JAMES RDirectorSep 15 '26Option Exercise58.7230,0001,761,45030,000Sep 16 04:35 PM
TOBIN JAMES RDirectorSep 15 '26Sale74.5830,0002,237,5020Sep 16 04:35 PM
TOBIN JAMES RDirectorSep 15 '26Proposed Sale74.5330,0002,236,000Sep 15 02:28 PM
ZARRILLI STEPHEN TDirectorAug 18 '26Option Exercise53.2725,0001,331,75025,000Aug 19 05:07 PM
ZARRILLI STEPHEN TDirectorAug 18 '26Sale87.0425,0002,175,9650Aug 19 05:07 PM
ZARRILLI STEPHEN TDirectorAug 18 '26Proposed Sale87.0425,0002,176,000Aug 18 04:23 PM
Davidar David DDirectorJun 05 '26Option Exercise26.2725,000656,750535,175Jun 09 05:04 PM
Davidar David DDirectorJun 05 '26Sale80.7625,0002,019,072510,175Jun 09 05:04 PM
RHOADS ANN DDirectorJun 04 '26Option Exercise26.2725,000656,75040,384Jun 08 05:14 PM
Davidar David DDirectorJun 05 '26Proposed Sale81.0025,0002,025,000Jun 05 03:15 PM
DeFord John AFormer DirectorApr 14 '26Proposed Sale93.1030,0002,793,128Apr 14 03:34 PM

Held by

AUM
TickerCompanyAUM
IJHiShares Core S&P Mid-Cap ETFAUM: 124.48B
VTIVanguard Morningstar Total Stock Market ETFAUM: 687.42B
VBVanguard Morningstar Small-Cap ETFAUM: 79.59B
VBKVanguard Morningstar Small-Cap Growth ETFAUM: 22.34B
VXFVanguard Extended Market Index ETFAUM: 30.47B
DFATU.S. Targeted Value Portfolio-ETF Class SharesAUM: 14.47B
MDYState Street SPDR S&P MIDCAP 400 ETF TrustAUM: 26.22B
IJKiShares S&P Mid-Cap 400 Growth ETFAUM: 10.46B
DFASU.S. Small Cap Portfolio-ETF Class SharesAUM: 15.51B
SPMDState Street SPDR Portfolio S&P 400TM Mid Cap ETFAUM: 18.90B

News

latest 14 of 200

Quarterly earnings

actual against estimate
PeriodReportedEPS actEPS estEPS repSales actSales estAnalysts
2026Q32026-11-051.2301.1971.040763.72792.3913
2026Q22026-08-061.3401.0991.103789.61782.8815
2026Q12026-05-071.1200.9200.900759.85740.3514
2025Q42026-02-241.2801.1341.029826.42801.6515
2025Q32025-11-061.1800.7810.879769.05734.6912
2025Q22025-08-070.8600.7531.486745.34741.114
2025Q12025-05-080.6800.7440.540598.12625.8915
2024Q42025-02-200.8400.7480.190657.29645.715
2024Q32024-11-050.8300.6470.375625.71604.6914
2024Q22024-08-060.7500.6770.232629.69615.3315
2024Q12024-05-070.7200.567-0.053606.67586.8215
2023Q42024-02-200.6000.5840.108616.53608.7714
2023Q32023-11-070.5700.5400.009383.64306.7812
2023Q22023-08-030.6300.5910.567291.62279.5414
2023Q12023-05-040.5300.5090.481276.69253.6914
2022Q42023-02-210.5900.5600.490274.5276.6715

Annual earnings

PeriodEPS actEPS estEPS repSales actSales est
2019FY1.6801.7151.522785.37784.53
2020FY1.4401.3581.013789.04786.87
2021FY2.0402.0211.440958.1951.95
2022FY2.0602.0311.8531,0231,025
2023FY2.3202.3081.0721,5681,559
2024FY3.1402.9880.7472,5192,507
2025FY3.9803.8543.9202,9392,912
2026FY-4.979--3,100
2027FY-5.345--3,270
2028FY-5.860--3,445
2029FY-6.433--3,613
2030FY-7.460--4,331

Estimate revisions

last 14 periods
PeriodTypeDateEstimatesUpDownMeanLowHigh
2026Q4S2026-11-0914013783.4773.1853.9
2026Q4S2026-11-0614014783.4773.1853.9
2026Q4S2026-11-051401857.73842.7877
2026Q4S2026-10-211401857.73842.7877
2026Q4S2026-10-151406857.73842.7877
2026Q4S2026-09-171506857.92842.7877
2026Q4S2026-08-261506857.92842.7877
2026Q4S2026-08-211505858.61842.7877
2026Q4S2026-08-201505858.61842.7877
2026Q4S2026-08-191505858.61842.7877
2026Q4S2026-08-111505858.61842.7877
2026Q4S2026-08-071505858.42842.7877
2026Q4S2026-07-271510862.62849.4879.9
2026Q4S2026-07-221410862.85849.4879.9

Estimate history

EPS, annual1.0971.5441.5221.0131.441.8531.0720.7473.9244.0701
Period201720182019202020212022202320242025TTM
EPS, quarterly0.3750.190.541.4860.8791.0290.91.1031.038
PeriodQ3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26
Sales, annual635.977712.969785.368789.042958.1021022.8431568.4762519.3552938.9313139.61
Period201720182019202020212022202320242025TTM
Sales, quarterly625.705657.293598.121745.342769.048826.42759.854789.612763.719
PeriodQ3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26
Shares, annual96.65898.57399.82599.714101.544100.192136.336137.42135.055132.665
Period201720182019202020212022202320242025MRQ
Shares, quarterly135.904137.42135.356135.05134.605135.055135.666134.252132.665
PeriodQ3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26

Income statement, annual

Currency USD, millions
MetricTTM2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY
Total Revenue3,139.612,938.932,519.361,568.481,022.84958.10789.04785.37712.97
Cost of Goods Sold Incl. D&A1,084.051,076.001,154.85599.21281.46257.75234.29193.78169.00
Gross Profit2,055.551,862.931,364.50969.27741.38700.35554.75591.58543.97
Selling, General and Administrative Excl. Other1,334.751,322.171,132.19767.42504.98471.18414.86414.83367.09
Research and Development143.52146.94151.14124.0172.8663.0360.1060.0755.50
Other Operating Expense0.000.000.000.000.000.000.000.000.00
Operating Income720.80540.76232.31201.85236.40229.17139.89176.75176.88
Interest Expense--4.19-0.000.000.000.000.00
Unusual Expense38.6658.5266.3268.718.4557.2228.464.767.54
Net Income Before Taxes699.39605.07120.72165.39243.02180.41125.90189.95188.60
Income Taxes141.7667.2017.7442.5252.8531.2223.6134.7432.13
Consolidated Net Income557.64537.87102.98122.87190.17149.19102.28155.21156.47
Net Income From Continuing Operations557.64537.87102.98122.87190.17149.19102.28155.21156.47
Net Income557.64537.87102.98122.87190.17149.19102.28155.21156.47
EPS (Recurring)4.304.221.081.491.911.831.211.551.60
EPS (Basic, Before Extraordinaries)4.143.980.761.091.891.481.041.571.60
EPS (Diluted)4.073.920.751.071.851.441.011.521.54
EBITDA1,001.33818.24486.34346.58304.65299.04202.76229.49218.51
Non-Operating Income (Expense)17.25122.82-41.0832.2515.078.4514.4717.9619.27
Other After Tax Adjustments0.000.000.000.000.000.000.000.000.00
Stock Option Compensation Expense38.9960.4642.8941.6926.4422.8119.9519.2817.55
Price To Earnings Ratio18.5218.52124.7734.4749.2150.1065.0538.7228.03
Price To Sales Ratio3.244.074.533.897.457.818.357.656.15
Gross Margin65.4763.3954.1661.8072.4873.1070.3175.3376.30
Operating Margin22.9618.409.2212.8723.1123.9217.7322.5124.81
Net Margin17.7618.304.097.8318.5915.5712.9619.7621.95
Shares Outstanding132.67135.06137.42136.34100.19101.5499.7199.8398.57
Market Capitalization10,122.0110,122.0111,262.377,342.997,414.497,325.416,435.375,852.854,260.92

Income statement, quarterly

Currency USD, millions
Metric2026Q32026Q22026Q12025Q42025Q32025Q22025Q12024Q4
Total Revenue763.72789.61759.85826.42769.05745.34598.12657.29
Cost of Goods Sold Incl. D&A262.49269.10262.00290.47282.38278.95224.20293.35
Gross Profit501.23520.52497.85535.95486.67466.39373.92363.94
Selling, General and Administrative Excl. Other323.00323.14334.28354.32351.99340.16275.71274.28
Research and Development34.5336.3236.5136.1638.0739.7432.9720.80
Other Operating Expense0.000.000.000.000.000.000.000.00
Operating Income178.23197.37163.57181.63134.69126.2398.2289.67
Unusual Expense0.6814.9413.189.86-2.6850.121.2129.39
Net Income Before Taxes183.27189.82157.07169.23143.99188.17103.6724.67
Income Taxes42.1038.2532.7728.6425.03-14.6728.21-1.84
Consolidated Net Income141.17151.57124.30140.59118.97202.8575.4626.50
Net Income From Continuing Operations141.17151.57124.30140.59118.97202.8575.4626.50
Net Income141.17151.57124.30140.59118.97202.8575.4626.50
EPS (Recurring)1.041.180.971.080.861.740.550.34
EPS (Basic, Before Extraordinaries)1.051.120.921.050.881.500.550.19
EPS (Diluted)1.041.100.901.030.881.490.540.19
EBITDA249.16267.46233.43251.28205.81196.86164.29157.90
Non-Operating Income (Expense)5.727.386.69-2.546.63112.066.66-35.61
Other After Tax Adjustments0.000.000.000.000.000.000.000.00
Stock Option Compensation Expense9.3210.6010.108.979.0910.7610.539.48
Price To Earnings Ratio18.5218.4021.9028.2222.1044.1598.33124.77
Price To Sales Ratio3.243.453.844.062.803.074.074.59
Gross Margin65.6365.9265.5264.8563.2862.5762.5255.37
Operating Margin23.3425.0021.5321.9817.5116.9416.4213.64
Net Margin18.4819.2016.3617.0115.4727.2212.624.03
Shares Outstanding132.67134.25135.67135.06134.61135.05135.36137.42
Market Capitalization10,122.0110,718.9711,636.3411,752.367,734.317,990.0710,068.0711,262.37

Balance sheet, annual

Currency USD, millions
Metric2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY
Cash & Short Term Investments557.24890.06517.79446.06443.45426.74311.49339.68373.71
Short Term Receivables743.66578.33504.87217.31165.65148.10162.42144.36127.06
Inventories759.28659.23848.13298.98237.00229.15196.31131.25108.41
Other Current Assets65.4349.6444.5821.0018.4217.7717.2415.3911.17
Total Current Assets2,125.612,177.261,915.37983.34864.52821.76687.47630.68620.34
Net Property, Plant & Equipment628.96612.07647.66243.73226.09221.62202.32171.87143.17
Total Investments and Advances71.8266.1375.43495.85562.48358.52409.51263.1256.13
Long-Term Note Receivable-------0.0028.33
Intangible Assets2,180.102,227.502,359.14261.05248.37243.66207.59211.06202.55
Deferred Tax Assets218.2294.2010.6948.8424.496.625.9313.5820.03
Other Assets78.0674.5877.7943.3131.3227.3019.2610.367.95
Total Assets5,302.765,251.755,086.082,076.131,957.261,679.481,532.081,300.671,078.50
Short Term Debt Incl. Current Port. of LT Debt15.09453.8312.440.002.121.861.340.000.00
Accounts Payable98.8575.1256.6736.1021.9518.2024.6125.8925.04
Income Tax Payable4.1610.723.850.991.051.101.060.923.27
Other Current Liabilities380.41316.24319.39122.11115.0599.6284.3969.3164.76
Total Current Liabilities498.50855.91392.35159.20140.16120.79111.4096.1293.07
Long Term Debt104.3583.89508.770.002.942.941.140.000.00
Provision for Risks Charges0.000.000.000.000.000.000.000.004.51
Deferred Tax Liabilities23.7623.8984.421.784.316.206.028.1110.67
Other Liabilities102.90110.73102.5868.7768.4643.2611.0610.922.47
Total Liabilities729.511,074.421,088.12229.75215.88173.19129.62115.15110.72
Non-Equity Reserves0.000.000.000.000.000.000.000.000.00
Preferred Stock - Carrying Value0.000.000.000.000.000.000.000.000.00
Common Equity4,573.254,177.333,997.961,846.371,741.391,506.301,402.451,185.52967.78
Total Shareholders Equity4,573.254,177.333,997.961,846.371,741.391,506.301,402.451,185.52967.78
Accumulated Minority Interest0.000.000.000.000.000.000.000.000.00
Total Equity4,573.254,177.333,997.961,846.371,741.391,506.301,402.451,185.52967.78
Total Liabilities & Stockholders Equity5,302.765,251.755,086.082,076.131,957.261,679.481,532.081,300.671,078.50
Book Value Per Share33.8630.4029.3218.4317.1515.1114.0512.0310.01
Tangible Book Value Per Share17.7214.1912.0215.8214.7012.6611.979.897.92
Full-Time Employees6,0005,3005,0002,6002,4002,2002,0001,8001,500
Price to Book Ratio2.092.761.794.204.214.324.193.604.23
Return on Assets10.191.993.439.438.206.3710.9613.1510.70
Return on Equity12.292.524.2010.609.197.0311.9914.5311.93
Return on Invested Capital11.502.422.7310.308.556.7811.0613.2011.09
Quick Ratio2.741.772.724.304.484.914.415.205.50
Current Ratio4.262.544.886.186.176.806.176.566.67

Cash flow, annual

Currency USD, millions
MetricTTM2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY
Net Income557.64537.87102.98122.87190.17149.19102.28155.21156.47
Depreciation278.74276.84254.02144.7368.2569.8762.8752.7341.63
Other Funds (Non Cash)127.95-13.09387.09150.2847.5392.0875.5633.1732.44
Funds from Operations1,007.20820.24618.19360.10283.73293.53236.38245.42231.51
Extraordinary Item0.000.000.000.000.000.000.000.000.00
Changes in Working Capital-81.28-66.80-97.55-116.60-105.26-17.25-37.59-73.44-49.87
Cash from Operating Activities925.92753.45520.64243.50178.47276.27198.79171.97181.64
Capital Expenditures-159.37-174.43-115.43-78.27-74.05-56.90-63.66-70.75-59.70
Net Assets From Acquisitions-22.42-252.55-17.64-296.03-31.43-34.49-33.48-23.80-14.82
Sale of Fixed Assets and Businesses0.000.000.000.000.000.000.000.005.00
Purchase or Sale of Investments-397.2171.96-42.99677.27-4.88-284.55-20.18-45.73-153.50
Purchase of Investments-469.26-107.53-113.50-100.64-419.53-622.36-223.54-346.53-537.94
Sale Or Maturity of Investments72.06179.4970.52777.91414.65337.81203.36300.79384.44
Other Uses20.000.000.000.000.000.000.000.000.00
Other Sources-20.000.000.000.000.000.000.000.0030.00
Cash from Investing Activities-579.07-355.01-176.05302.97-110.36-375.94-117.32-140.28-193.03
Cash Dividends Paid0.000.000.000.000.000.000.000.000.00
Change in Capital Stock-208.43-210.6924.65-213.16-102.7863.50-32.3531.0439.31
Repurchase of Common Pref Stock-324.00-300.45-85.79-225.56-144.490.00-104.670.000.00
Sale of Common Pref Stock115.5789.76110.4412.4041.7263.5072.3231.0439.31
Proceedsfrom Stock Options0.000.000.000.000.000.000.000.000.00
Issuance or Reduction of Debt, Net0.00-449.990.000.000.000.000.000.000.00
Change in Long Term Debt0.00-449.990.000.000.000.000.000.000.00
Issuance of Long Term Debt0.000.000.000.000.000.000.000.000.00
Reduction of Long Term Debt0.00-449.990.000.000.000.000.000.000.00
Net Financing Active Other Cash Flow-25.41-18.48-52.35-18.66-7.18-9.35-6.32-6.60-6.74
Other Financing Activities Uses-25.41-18.48-52.35-18.66-7.18-9.35-6.32-6.60-6.74
Cash from Financing Activities-233.84-679.16-27.70-231.82-109.9654.15-38.6624.4432.57
Exchange Rate Effect2.9222.450.262.18-0.75-0.810.86-0.16-0.26
Net Change in Cash115.92-258.28317.15316.83-42.60-46.3343.6755.9820.93
Free Cash Flow766.55588.77405.21165.22104.42219.38135.13101.22121.95
Preferred Dividends (Cash Flow)-0.000.000.000.000.000.000.000.00
Price to Free Cash Flow13.2920.3228.1436.9773.0134.1048.7359.3335.96
Deferred Taxes & Investment Tax Credit-18.62-125.90-57.79-22.22-17.61-4.344.300.97

Balance sheet, quarterly

Currency USD, millions
Metric2026Q32026Q22026Q12025Q42025Q32025Q2
Cash & Short Term Investments517.43595.14629.85557.24390.52229.45
Short Term Receivables723.95739.28735.44743.66688.12660.12
Inventories824.14810.90772.60759.28771.54772.13
Other Current Assets116.4470.1960.2365.4374.1868.20
Total Current Assets2,181.962,215.512,198.122,125.611,924.361,729.90
Net Property, Plant & Equipment590.14593.38619.34628.96637.92649.39
Total Investments and Advances353.74245.36169.4471.8216.680.00
Intangible Assets2,121.032,130.842,159.582,180.102,208.192,231.36
Deferred Tax Assets205.94224.63214.81218.22232.36275.90
Other Assets75.3878.5478.2778.0676.1274.55
Total Assets5,528.195,488.265,439.565,302.765,095.644,961.09
Short Term Debt Incl. Current Port. of LT Debt14.4814.7215.4415.0914.7013.31
Accounts Payable107.43106.94103.6698.8587.2387.10
Income Tax Payable5.846.043.034.161.280.00
Other Current Liabilities380.18351.64360.33380.41362.75324.25
Total Current Liabilities507.94479.35482.46498.50465.96424.66
Long Term Debt93.7097.19100.50104.35105.42108.10
Provision for Risks Charges0.000.000.000.000.000.00
Deferred Tax Liabilities31.6042.3424.6623.7622.5424.40
Other Liabilities98.70100.7899.62102.90102.90108.24
Total Liabilities731.94719.65707.24729.51696.82665.41
Non-Equity Reserves0.000.000.000.000.000.00
Preferred Stock - Carrying Value0.000.000.000.000.000.00
Common Equity4,796.254,768.604,732.314,573.254,398.824,295.68
Total Shareholders Equity4,796.254,768.604,732.314,573.254,398.824,295.68
Accumulated Minority Interest0.000.000.000.000.000.00
Total Equity4,796.254,768.604,732.314,573.254,398.824,295.68
Total Liabilities & Stockholders Equity5,528.195,488.265,439.565,302.765,095.644,961.09
Book Value Per Share36.1535.5234.8833.8632.6831.81
Tangible Book Value Per Share20.1719.6518.9617.7216.2715.29
Full-Time Employees---6,000--
Price to Book Ratio2.092.272.542.671.801.95
Return on Assets10.5010.2511.5610.198.327.17
Return on Equity12.1311.8113.3012.2910.018.62
Return on Invested Capital2.893.112.573.012.644.61
Quick Ratio2.672.932.952.742.472.26
Current Ratio4.304.624.564.264.134.07

Cash flow, quarterly

Currency USD, millions
Metric2026Q32026Q22026Q12025Q42025Q32025Q2
Net Income141.17151.57124.30140.59118.97202.85
Depreciation70.3869.5069.8669.0171.1370.63
Other Funds (Non Cash)21.2435.9528.3642.3916.10-97.24
Funds from Operations241.82264.81230.48270.10247.95134.49
Extraordinary Item0.000.000.000.000.000.00
Changes in Working Capital23.41-55.06-28.12-21.511.74-56.63
Cash from Operating Activities265.23209.74202.36248.59249.6977.86
Capital Expenditures-40.39-33.17-39.62-46.28-40.48-46.56
Net Assets From Acquisitions-16.01-1.50-4.910.000.00-252.55
Sale of Fixed Assets and Businesses0.000.000.000.000.000.00
Purchase or Sale of Investments-99.51-94.38-138.15-65.17-35.360.00
Purchase of Investments-144.83-107.62-146.39-70.42-35.360.00
Sale Or Maturity of Investments45.3213.248.245.250.000.00
Other Uses0.000.000.0020.00-20.000.00
Other Sources0.000.000.00-20.0020.000.00
Cash from Investing Activities-155.90-129.05-182.67-111.45-75.84-299.11
Cash Dividends Paid0.000.000.000.000.000.00
Preferred Dividends (Cash Flow)0.000.000.000.000.000.00
Change in Capital Stock-127.06-125.0925.9617.76-28.92-20.30
Repurchase of Common Pref Stock-142.94-136.060.00-45.00-40.00-25.00
Sale of Common Pref Stock15.8810.9725.9662.7611.084.70
Proceedsfrom Stock Options0.000.000.000.000.000.00
Issuance or Reduction of Debt, Net0.000.000.000.000.000.00
Change in Long Term Debt0.000.000.000.000.000.00
Issuance of Long Term Debt0.000.000.000.000.000.00
Reduction of Long Term Debt0.000.000.000.000.000.00
Net Financing Active Other Cash Flow-3.70-9.41-7.76-4.54-3.12-4.63
Other Financing Activities Uses-3.70-9.41-7.76-4.54-3.12-4.63
Cash from Financing Activities-130.76-134.5018.2013.21-32.04-24.94
Exchange Rate Effect1.380.60-3.094.030.5114.36
Net Change in Cash-20.06-53.2034.79154.39142.32-231.82
Free Cash Flow224.84176.57162.75202.39213.8831.30
Price to Free Cash Flow13.2914.3719.5120.2513.3815.27

Revenue breakdown

Enabling Technologies2024: 154.00M 2025: 141.01M
Musculoskeletal Solutions2024: 2.37B 2025: 2.80B
Non-US2024: 519.29M 2025: 571.34M
United States2024: 2.00B 2025: 2.37B

Short interest

shares short against float, oldest to newest
SettlementOf floatShares shortFloatAvg volume
2026-10-308.52%9.5M111.0M1.41M
2026-10-157.38%8.2M111.0M1.45M
2026-09-307.60%8.4M111.0M1.53M
2026-09-156.10%6.8M111.0M1.60M
2026-08-315.96%6.6M111.0M1.62M
2026-08-146.13%6.8M111.0M1.78M
2026-07-316.16%6.9M111.8M1.86M
2026-07-156.29%7.1M112.4M1.77M
2026-06-306.59%7.4M112.4M1.63M
2026-06-154.87%5.5M112.4M1.44M
2026-05-293.48%3.9M112.4M1.34M
2026-05-153.04%3.4M112.4M1.25M
2026-04-302.79%3.1M111.8M1.09M
2026-04-152.96%3.3M111.8M1.13M
2026-03-312.53%2.8M111.8M1.28M
2026-03-132.95%3.3M111.8M1.32M
2026-02-272.92%3.3M111.8M1.39M
2026-02-134.20%4.7M111.4M1.46M
2026-01-303.70%4.1M111.4M1.78M
2026-01-153.48%3.9M111.4M1.79M

Option chain

expiry 2026-11-20
TypeStrikeBidAskLastIVOpen intVolumeDeltaThetaVega
call55.0018.3022.000.001.9910.000.000.950-0.0960.012
call60.0013.4017.1023.201.6254.000.000.871-0.2060.025
call65.008.4012.100.001.2330.000.000.835-0.1830.029
call67.506.009.800.001.0940.000.000.794-0.1870.033
call70.003.707.200.000.8660.000.000.762-0.1560.036
call72.501.854.804.200.6800.000.000.675-0.1550.042
call75.001.002.502.590.48815.000.000.544-0.1460.046
call77.500.552.800.650.7256132.000.423-0.1840.046
call80.000.200.650.430.46274.002.000.257-0.1190.038
call82.500.001.107.250.59658.000.000.185-0.1090.031
call85.000.001.950.050.71764916.000.155-0.1150.028
call87.500.002.150.950.8301510.000.139-0.1230.026
call90.000.002.150.150.9345640.000.127-0.1300.024
call92.500.002.150.001.0330.000.000.117-0.1360.023
call95.000.002.150.081.1266.001.000.110-0.1410.022
call1000.002.150.001.3000.000.000.098-0.1500.020
call1050.002.150.001.4590.000.000.090-0.1570.019
call1100.002.150.001.6070.000.000.083-0.1640.018
put55.000.002.150.001.3170.000.00-0.050-0.0900.012
put60.000.002.150.951.44014.000.00-0.129-0.1990.025
put65.000.001.200.300.9003.000.00-0.147-0.1340.027
put67.500.002.350.430.95711.000.00-0.206-0.1790.033
put70.000.001.400.430.7135010.00-0.238-0.1490.036
put72.500.601.550.850.60517.001.00-0.325-0.1470.042
put75.000.352.501.850.5821,4020.00-0.455-0.1320.046
put77.501.754.205.800.6455610.00-0.577-0.1750.046
put80.003.906.905.000.8801,5730.00-0.743-0.1100.038
put82.506.309.3010.321.0221.000.00-0.815-0.1000.031
put85.008.2011.8011.001.17230.000.00-0.845-0.1050.028
put87.5011.3014.0012.901.23093.000.00-0.861-0.1130.026
put90.0013.0016.808.501.4380.000.00-0.873-0.1200.024
put92.5016.1019.300.001.5580.000.00-0.883-0.1250.023
put95.0018.6021.800.001.6720.000.00-0.890-0.1300.022
put10023.5026.800.001.8830.000.00-0.902-0.1390.020
put10528.2031.800.002.0750.000.00-0.910-0.1460.019
put11033.3036.800.002.2520.000.00-0.917-0.1520.018

Latest SEC filings

30
FiledFormDescriptionPeriodLink
2026-11-10144Filing for proposed sale of securities under Rule 144.SEC
2026-11-0510-QQuarterly report pursuant to Section 13 or 15(d)2026-09-30SEC
2026-11-058-KCurrent report2026-11-05SEC
2026-11-054Statement of changes in beneficial ownership of securities2026-11-04SEC
2026-11-04144Filing for proposed sale of securities under Rule 144.SEC
2026-10-30SCHEDULE 13G/ASEC
2026-10-27SCHEDULE 13G/ASEC
2026-09-164Statement of changes in beneficial ownership of securities2026-09-15SEC
2026-09-15144Filing for proposed sale of securities under Rule 144.SEC
2026-08-194Statement of changes in beneficial ownership of securities2026-08-18SEC
2026-08-18144Filing for proposed sale of securities under Rule 144.SEC
2026-08-0610-QQuarterly report pursuant to Section 13 or 15(d)2026-06-30SEC
2026-08-068-KCurrent report2026-08-06SEC
2026-07-284Statement of changes in beneficial ownership of securities2026-07-27SEC
2026-06-094Statement of changes in beneficial ownership of securities2026-06-05SEC
2026-06-084Statement of changes in beneficial ownership of securities2026-06-04SEC
2026-06-05144Filing for proposed sale of securities under Rule 144.SEC
2026-06-048-KCurrent report2026-06-03SEC
2026-05-27SDSpecialized Disclosure ReportSEC
2026-05-0710-QQuarterly report pursuant to Section 13 or 15(d)2026-03-31SEC
2026-05-078-KCurrent report2026-05-07SEC
2026-04-30SCHEDULE 13GSEC
2026-04-24DEFA14AProxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934SEC
2026-04-24DEF 14AProxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 19342026-06-03SEC
2026-04-14144Filing for proposed sale of securities under Rule 144.SEC
2026-03-26SCHEDULE 13G/ASEC
2026-03-238-KCurrent report2026-03-23SEC
2026-02-274Statement of changes in beneficial ownership of securities2026-02-25SEC
2026-02-25144Filing for proposed sale of securities under Rule 144.SEC
2026-02-2410-KAnnual report pursuant to Section 13 or 15(d)2025-12-31SEC

Insider activity by month

MonthBoughtBuysSoldSells
2026-1100425.00K1
2026-100000
2026-09002.24M1
2026-08002.18M1
2026-070000
2026-06002.02M1
2026-050000
2026-040000
2026-030000
2026-02002.77M2
2026-0100565.55K2
2025-12002.02M2
2025-11005.75M5

Institutional holders

Manager% owned
BlackRock, Inc.7.97%
Jupiter Topco LLC6.04%
VANGUARD CAPITAL MANAGEMENT LLC3.76%
VANGUARD PORTFOLIO MANAGEMENT LLC3.68%
Invesco Ltd.3.18%
KAYNE ANDERSON RUDNICK INVESTMENT MANAGEMENT LLC3.15%
STATE STREET CORP2.74%
Boston Partners2.54%
DIMENSIONAL FUND ADVISORS LP2.24%
Sculptor Capital LP2.21%

Funds

Fund% owned
iShares Core S&P Mid-Cap ETF2.86%
VANGUARD TOTAL STOCK MARKET INDEX FUND2.65%
VANGUARD SMALL-CAP INDEX FUND1.91%
Janus Henderson Enterprise Fund1.63%
VANGUARD SMALL-CAP GROWTH INDEX FUND1.10%
JPMorgan Mid Cap Value Fund1.09%
VANGUARD EXTENDED MARKET INDEX FUND0.96%
Allspring Special Mid Cap Value Fund0.91%
Janus Henderson Triton Fund0.82%
Invesco Small Cap Value Fund0.75%

OakChart. GMED. Cached 15 minutes.